Free Trial

10 Best Penny Stocks to Buy Now - 3 of 10

 
 

GeoVax Labs (NASDAQ:GOVX)

Number of Upgrades from Top-Ranked Analysts
6 (in the last 90 days)
Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$12.90 (1,190.9% Upside)

About GeoVax Labs

GeoVax Labs logoGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. More about GeoVax Labs
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/16/2025HC WainwrightReiterated RatingBuy ➝ Buy$8.00 ➝ $8.00
4/15/2025Alliance Global PartnersLower Price TargetBuy ➝ Buy$15.00 ➝ $8.50
4/10/2025D. Boral CapitalReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
3/28/2025D. Boral CapitalReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
2/27/2025D. Boral CapitalReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
1/31/2025D. Boral CapitalReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
1/16/2025D. Boral CapitalReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
12/18/2024D. Boral CapitalReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
11/19/2024D. Boral CapitalReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
11/15/2024HC WainwrightReiterated RatingBuy ➝ Buy$8.00 ➝ $8.00